{"nctId":"NCT01993849","briefTitle":"Use of N-Acetylcysteine (NAC) in Fingernail Biting","startDateStruct":{"date":"2013-10"},"conditions":["Onychophagia"],"count":23,"armGroups":[{"label":"N-Acetylcysteine (NAC)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: N-Acetylcysteine (NAC)"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"N-Acetylcysteine (NAC)","otherNames":["NAC"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 1\\. Age 18-30 2. Fingernail biter for â‰¥5 years\n\nExclusion Criteria:\n\n* 1\\. Any unstable major DSM-IV Axis I psychiatric disorder in the past month (e.g., psychotic disorders, bipolar disorder, major depressive disorder) 2. Current substance dependence in the past month 3. Current unstable major medical disorder or medical condition in the past 6 months (e.g., renal impairment) 4. Current pregnancy or breastfeeding 5. Current seizure disorder or asthma, due to possible elevated risk for adverse effects with NAC in individuals with these conditions 6. Known hypersensitivity to NAC 7. Use of carbamazepine or nitroglycerin (or any other medication deemed to be hazardous if taken with NAC) within 14 days of study participation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"30 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Enrolled Within One Year","description":"Ability to enroll the goal sample within one year; we are interested in the feasibility of sufficient enrollment and data collection within a given period of time.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Measurement of Nail Length","description":"Length of nails, measured by caliper","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.12","spread":"2.43"},{"groupId":"OG001","value":"10.73","spread":"3.40"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Headache"]}}}